BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 23303421)

  • 1. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A; von Knorring L; Ljung T; Carlborg A; Brus O; Engström I
    J ECT; 2013 Jun; 29(2):86-92. PubMed ID: 23303421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
    J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
    Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
    Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy.
    Martínez-Amorós E; Cardoner N; Soria V; Gálvez V; Menchón JM; Urretavizcaya M
    J ECT; 2012 Jun; 28(2):92-7. PubMed ID: 22531201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study.
    Smith GE; Rasmussen KG; Cullum CM; Felmlee-Devine MD; Petrides G; Rummans TA; Husain MM; Mueller M; Bernstein HJ; Knapp RG; O'Connor MK; Fink M; Sampson S; Bailine SH; Kellner CH;
    J Clin Psychiatry; 2010 Feb; 71(2):185-93. PubMed ID: 20193646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    McCall WV; Rosenquist PB; Kimball J; Haskett R; Isenberg K; Prudic J; Lasater B; Sackeim HA
    J ECT; 2011 Jun; 27(2):97-102. PubMed ID: 21206285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.
    Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH
    J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA; Haskett RF; Mulsant BH; Thase ME; Mann JJ; Pettinati HM; Greenberg RM; Crowe RR; Cooper TB; Prudic J
    JAMA; 2001 Mar; 285(10):1299-307. PubMed ID: 11255384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.
    van Beusekom BS; van den Broek WW; Birkenhäger TK
    J ECT; 2007 Mar; 23(1):17-20. PubMed ID: 17435567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
    Rasmussen KG; Knapp RG; Biggs MM; Smith GE; Rummans TA; Petrides G; Husain MM; O'Connor MK; Fink M; Kellner CH
    J ECT; 2007 Dec; 23(4):244-50. PubMed ID: 18090697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation ECT: relapse prevention in affective disorders.
    Petrides G; Dhossche D; Fink M; Francis A
    Convuls Ther; 1994 Sep; 10(3):189-94. PubMed ID: 7834255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
    Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
    Prudic J; Haskett RF; McCall WV; Isenberg K; Cooper T; Rosenquist PB; Mulsant BH; Sackeim HA
    J ECT; 2013 Mar; 29(1):3-12. PubMed ID: 23303417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.
    Maina G; Rosso G; Bogetto F
    J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2006 Feb; 67(2):263-8. PubMed ID: 16566622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients.
    Gagné GG; Furman MJ; Carpenter LL; Price LH
    Am J Psychiatry; 2000 Dec; 157(12):1960-5. PubMed ID: 11097961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.